Company page

Xeno Transplants Corporation

Xeno Transplants Corporation, trading under the ticker XENO, is a public company based in America with a market capitalization of approximately $4.04 billion. The company focuses on innovative solutions in the field of organ transplantation. Xeno aims to address the growing demand for organ transplants through its advanced technologies and research initiatives.